Analyst Consensus ?
ConsensusHold41 ratings
Bullish1843.9%
Neutral2151.2%
Bearish24.9%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Bristol-Myers Squibb Company analyst ratings
Bristol-Myers Squibb Company (BMY) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$61.61Current
$37Low
$64.18Average
$92High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 13, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Oct 8, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Oct 7, 2026 |
| Leerink Partners | Market Perform | Outperform | Downgrade | Oct 5, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Sep 16, 2026 |
| HSBC | Hold | Hold | Maintain | Sep 10, 2026 |
| Argus Research | Buy | Hold | Upgrade | Aug 5, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 31, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 31, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 31, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 10, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Jan 9, 2026 |
| UBS | Buy | Neutral | Upgrade | Jan 7, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Dec 2, 2025 |
| Jefferies | Buy | Buy | Maintain | Apr 23, 2025 |
| BMO Capital | Market Perform | Market Perform | Maintain | Nov 12, 2024 |
| TD Cowen | Hold | Hold | Maintain | Oct 7, 2024 |
| Barclays | Underweight | Underweight | Maintain | Oct 7, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 23, 2024 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Feb 6, 2024 |
| Daiwa Capital | Neutral | Outperform | Downgrade | Nov 2, 2023 |
| William Blair | Market Perform | Outperform | Downgrade | Oct 27, 2023 |
| Atlantic Equities | Overweight | Overweight | Maintain | Jul 28, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 28, 2023 |
| Berenberg | Hold | Buy | Downgrade | Sep 14, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Jun 6, 2022 |
| Mizuho | Buy | Buy | Maintain | Nov 17, 2020 |
| Societe Generale | Buy | Hold | Upgrade | Nov 16, 2020 |
| CFRA | Buy | Buy | Maintain | May 7, 2020 |
| Gabelli & Co. | Buy | Buy | Maintain | Nov 27, 2019 |
| Bank of America | Neutral | Neutral | Maintain | Oct 10, 2019 |
| Wolfe Research | Outperform | Outperform | Maintain | Oct 24, 2018 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| DZ Bank | Hold | Buy | Downgrade | Feb 28, 2018 |
| Leerink Swann | Outperform | Outperform | Maintain | Feb 6, 2018 |
| Hilliard Lyons | Neutral | Upgrade | Oct 28, 2016 | |
| PiperJaffray | Hold | Underperform | Upgrade | Aug 24, 2015 |
| Bernstein | Market Perform | Market Perform | Maintain | May 15, 2014 |
| Cowen & Co. | Outperform | Outperform | Maintain | May 14, 2014 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 29, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $61.61. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $78 | $61.48 | +26.6% | Oct 26, 2026 |
| Jefferies | Akash Tewari | $76 | $57.58 | +23.4% | Oct 12, 2026 |
| Cantor Fitzgerald | Carter Gould | $53 | $59.7 | -14.0% | Oct 8, 2026 |
| Morgan Stanley | Terence Flynn | $41 | $59.7 | -33.5% | Oct 7, 2026 |
| Leerink Partners | Analyst unavailable | $59 | $59.02 | -4.2% | Oct 5, 2026 |
| Goldman Sachs | Asad Haider | $63 | $62.25 | +2.3% | Sep 23, 2026 |
| Piper Sandler | Analyst unavailable | $82 | $63.73 | +33.1% | Sep 16, 2026 |
| HSBC | Analyst unavailable | $65 | $64.41 | +5.5% | Sep 10, 2026 |
| Roth Capital | Analyst unavailable | $75 | $63.47 | +21.7% | Aug 5, 2026 |
| Argus Research | Jasper Hellweg | $75 | $65.89 | +21.7% | Aug 5, 2026 |
| RBC Capital | Trung Huynh | $64 | $64.73 | +3.9% | Aug 4, 2026 |
| Cantor Fitzgerald | Carter Gould | $59 | $63.67 | -4.2% | Jul 31, 2026 |
| Guggenheim | Seamus Fernandez | $75 | $64.86 | +21.7% | Jul 31, 2026 |
| Wells Fargo | Analyst unavailable | $65 | $64.86 | +5.5% | Jul 31, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $54 | $59.2 | -12.4% | Apr 8, 2026 |
| UBS | Michael Yee | $70 | $59.78 | +13.6% | Mar 6, 2026 |
| RBC Capital | Trung Huynh | $60 | $61.6 | -2.6% | Feb 24, 2026 |
| Piper Sandler | Analyst unavailable | $75 | $60.66 | +21.7% | Feb 23, 2026 |
| Barclays | Analyst unavailable | $75 | $60.3 | +21.7% | Feb 19, 2026 |
| Morgan Stanley | Terence Flynn | $40 | $61.86 | -35.1% | Feb 6, 2026 |
| Guggenheim | Analyst unavailable | $72 | $59.52 | +16.9% | Feb 6, 2026 |
| Wells Fargo | Mohit Bansal | $60 | $59.52 | -2.6% | Feb 6, 2026 |
| Piper Sandler | Analyst unavailable | $66 | $55.56 | +7.1% | Jan 28, 2026 |
| Leerink Partners | David Risinger | $60 | $56.39 | -2.6% | Jan 13, 2026 |
| Scotiabank | Louise Chen | $60 | $55.86 | -2.6% | Jan 9, 2026 |
| UBS | Analyst unavailable | $65 | $56.42 | +5.5% | Jan 7, 2026 |
| Morgan Stanley | Analyst unavailable | $37 | $52.63 | -39.9% | Dec 12, 2025 |
| Guggenheim | Analyst unavailable | $62 | $51.2 | +0.6% | Dec 12, 2025 |
| HSBC | Analyst unavailable | $53 | $50.68 | -14.0% | Dec 10, 2025 |
| Scotiabank | Louis Chen | $53 | $50.96 | -14.0% | Dec 4, 2025 |
| Truist Financial | Srikripa Devarakonda | $65 | $50.98 | +5.5% | Dec 3, 2025 |
| Daiwa | Narumi Nakagiri | $42 | $45.85 | -31.8% | Aug 5, 2025 |
| Truist Financial | David Macdonald | $84 | $47.12 | +36.3% | Jul 21, 2025 |
| Jefferies | Akash Tewari | $68 | $48.52 | +10.4% | Apr 23, 2025 |
| Piper Sandler | David Amsellem | $65 | $49.82 | +5.5% | Apr 22, 2025 |
| BMO Capital | Evan Seigerman | $61 | $56.22 | -1.0% | Nov 12, 2024 |
| BMO Capital | Evan David Seigerman | $57 | $54.32 | -7.5% | Nov 1, 2024 |
| BMO Capital | Evan David Seigerman | $48 | $49.56 | -22.1% | Sep 23, 2024 |
| Goldman Sachs | Chris Shibutani | $57 | $50.54 | -7.5% | Jul 29, 2024 |
| Barclays | Carter Gould | $41 | $50.45 | -33.5% | Jul 29, 2024 |
| UBS | Trung Huynh | $43 | $40.68 | -30.2% | Jul 12, 2024 |
| Cowen & Co. | Steve Scala | $67 | $44.11 | +8.7% | May 16, 2024 |
| Deutsche Bank | James Shin | $55 | $49.87 | -10.7% | Jan 30, 2024 |
| BMO Capital | Evan Seigerman | $60 | $49.76 | -2.6% | Nov 27, 2023 |
| Leerink Partners | David Risinger | $66 | $56.24 | +7.1% | Oct 12, 2023 |
| Cantor Fitzgerald | Louise Chen | $75 | $59.67 | +21.7% | Sep 6, 2023 |
| Wells Fargo | Mohit Bansal | $70 | $78.22 | +13.6% | May 18, 2022 |
| BMO Capital | Analyst unavailable | $92 | $75.66 | +49.3% | May 2, 2022 |
| Barclays | Analyst unavailable | $68 | $75.27 | +10.4% | May 2, 2022 |
| Guggenheim | Seamus Fernandez | $80 | $75.27 | +29.8% | May 2, 2022 |
| BMO Capital | Evan Seigerman | $87 | $75.08 | +41.2% | May 2, 2022 |
| Morgan Stanley | Terence Flynn | $64 | $76.5 | +3.9% | Apr 11, 2022 |
| BMO Capital | Evan Seigerman | $81 | $73.79 | +31.5% | Apr 4, 2022 |
| Morgan Stanley | Matthew Harrison | $66 | $73.11 | +7.1% | Mar 28, 2022 |
| BMO Capital | Evan David Seigerman | $74 | $70.52 | +20.1% | Mar 17, 2022 |
| Barclays | Carter Gould | $66 | $56.22 | +7.1% | Oct 28, 2021 |
| Citigroup | Andrew Baum | $75 | $56.89 | +21.7% | Oct 25, 2021 |
| Guggenheim | Seamus Fernandez | $82 | $59.05 | +33.1% | Sep 20, 2021 |
| Societe Generale | Justin Smith | $85 | $63.63 | +38.0% | Sep 7, 2021 |
| Bank of America Securities | Geoff Meacham | $78 | $65.88 | +26.6% | Jul 27, 2021 |
Track every rating change on BMY the moment it posts. Free to start.
Start freeGet the BMY recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.